We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Eli Lilly In Hot Seat Again Over Zyprexa

Law360 (January 22, 2007, 12:00 AM EST) -- Fresh off a $495 million product-liability settlement over Zyprexa, Eli Lilly & Co. is facing more scrutiny, with Illinois and Vermont requesting that the pharmaceutical giant hand over material detailing how it marketed the top-selling schizophrenia drug.

The New York Times reported on Saturday that state prosecutors in both Illinois and Vermont demanded last week that Eli Lilly turn over marketing materials, e-mail messages and other documents regarding Zyprexa’s advertising campaign.

With the requests, the states have now joined a larger, five-state civil investigation into the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.